These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8977366)

  • 1. Inhibition of the renin-angiotensin system after acute myocardial infarction--treat first, select later?
    Hall AS; Sapsford R; Megarry SG; Ball SG
    Heart; 1996 Nov; 76(3 Suppl 3):73-8. PubMed ID: 8977366
    [No Abstract]   [Full Text] [Related]  

  • 2. The renin-angiotensin system and cardiac remodelling after acute myocardial infarction.
    Ikram H
    Heart; 1996 Nov; 76(3 Suppl 3):68-72. PubMed ID: 8983667
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of single or dual blockade of renin-angiotensin system in acute myocardial infarction patients according to renal function.
    Jeong HC; Jeong JM; Jeong MH; Ahn Y; Chae SC; Hur SH; Hong TJ; Kim YJ; Seong IW; Chae JK; Rhew JY; Chae IH; Cho MC; Bae JH; Rha SW; Kim CJ; Choi D; Jang YS; Yoon J; Chung WS; Cho JG; Seung KB; Park SJ;
    Int J Cardiol; 2012 Jun; 157(3):408-11. PubMed ID: 22513185
    [No Abstract]   [Full Text] [Related]  

  • 4. ACE inhibitors after myocardial infarction: selection and treatment for all.
    Coats AJ
    Br Heart J; 1995 May; 73(5):395-6. PubMed ID: 7786644
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use of captopril and other angiotensin-converting enzyme inhibitors in patients with myocardial infarction].
    Preobrazhenskiĭ DV
    Kardiologiia; 1993; 33(12):48-52. PubMed ID: 8196257
    [No Abstract]   [Full Text] [Related]  

  • 6. Angiotensin receptor blocker in patients with ST segment elevation myocardial infarction with preserved left ventricular systolic function: prospective cohort study.
    Yang JH; Hahn JY; Song YB; Choi SH; Choi JH; Lee SH; Jeong MH; Choi DJ; Park JS; Park HS; Gwon HC
    BMJ; 2014 Nov; 349():g6650. PubMed ID: 25398372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of RAA system and the treatment of patients with ACE inhibition after myocardial infarction.
    Ray SG; McAlpine HM; Morton JJ; Leckie B; Dargie HJ
    Angiology; 1991 Apr; 42(4):268-72. PubMed ID: 2014917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential role of renin-angiotensin system blockade for preventing myocardial ischemia/reperfusion injury and remodeling after myocardial infarction.
    Dai W; Kloner RA
    Postgrad Med; 2011 Mar; 123(2):49-55. PubMed ID: 21474893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Which patients should receive an ACE inhibitor after acute myocardial infarction?
    Kober L; Torp-Pedersen C; Burchardt H
    S Afr Med J; 1998 Apr; 88 Suppl 2():C81-4. PubMed ID: 9595001
    [No Abstract]   [Full Text] [Related]  

  • 10. The place of angiotensin-converting enzyme inhibition after acute myocardial infarction.
    Torp-Pedersen C; Køber L; Burchardt H
    Am Heart J; 1997 Aug; 134(2 Pt 2):S25-30. PubMed ID: 9313621
    [No Abstract]   [Full Text] [Related]  

  • 11. Angiotensin converting enzyme inhibition therapy following myocardial infarction. Rationale for clinical trials.
    Pfeffer MA
    Herz; 1991 Sep; 16 Spec No 1():278-82. PubMed ID: 1840297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can qualitative echocardiography be used to select patients for angiotensin-converting enzyme inhibitors following acute myocardial infarction?
    Darbar D; Gillespie N; Byrd BF
    Eur Heart J; 1996 Dec; 17(12):1783-6. PubMed ID: 8960416
    [No Abstract]   [Full Text] [Related]  

  • 13. Relative effectiveness of angiotensin-converting enzyme inhibitors after acute myocardial infarction.
    Lelorier JJ
    Am J Cardiol; 2007 Feb; 99(3):428-9. PubMed ID: 17261414
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of renin-angiotensin system inhibitors on long-term survival in patients treated with beta blockers and antiplatelet agents after acute myocardial infarction (from the MONICA/KORA Myocardial Infarction Registry).
    Amann U; Kirchberger I; Heier M; Zirngibl A; von Scheidt W; Kuch B; Peters A; Meisinger C
    Am J Cardiol; 2014 Aug; 114(3):329-35. PubMed ID: 24927969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of angiotensin-converting enzyme inhibitors after acute myocardial infarction.
    Mehra IV; Wilson MD
    Pharmacotherapy; 1993; 13(5):440-6. PubMed ID: 8247909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is there a link between the circulating renin-angiotensin system and coronary disease? A buoyant view.
    Alderman MH
    Heart; 1996 Nov; 76(3 Suppl 3):18-22. PubMed ID: 8977361
    [No Abstract]   [Full Text] [Related]  

  • 17. Angiotensin-converting enzyme inhibition and ventricular remodeling after myocardial infarction.
    Pfeffer JM; Fischer TA; Pfeffer MA
    Annu Rev Physiol; 1995; 57():805-26. PubMed ID: 7778884
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparing angiotensin-converting enzyme inhibitor trial results in patients with acute myocardial infarction.
    Cody RJ
    Arch Intern Med; 1994 Sep; 154(18):2029-36. PubMed ID: 8092908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of use of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers among patients with acute myocardial infarction in China from 2001 to 2011: China PEACE-Retrospective AMI Study.
    Liu J; Masoudi FA; Spertus JA; Wang Q; Murugiah K; Spatz ES; Li J; Li X; Ross JS; Krumholz HM; Jiang L;
    J Am Heart Assoc; 2015 Feb; 4(2):. PubMed ID: 25713293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Secondary prevention of ischemic heart disease: pharmacological treatment after myocardial infarction according to follow-up protocol].
    Milvidaite I; Luksiene D; Slapikiene B; Babarskiene MR; Liukaitis V; Maciulaitis R; Kadusevicius E; Pilviniene R
    Medicina (Kaunas); 2007; 43(2):131-6. PubMed ID: 17329948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.